The outlook of companies tied to Sildenafil's legacy presents a intricate investment picture . While the initial boom generated substantial gains, generic copies have significantly diminished revenue. https://wisesocialsmedia.com/story7150752/copyright-s-flagship-product-and-pharma-a-uncertain-venture